Effect of combination of Ceftaroline (CPT) and Avibactam in patients with Diabetic Foot Infections.

Trial Profile

Effect of combination of Ceftaroline (CPT) and Avibactam in patients with Diabetic Foot Infections.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Feb 2015

At a glance

  • Drugs Avibactam/ceftaroline fosamil (Primary)
  • Indications Bacterial infections; Diabetic foot; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 14 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top